Lodaer Img

Apigenin and CD38: The NAD+ Flavonoid Brands Should Watch

OSM Industry Intel • 2026 The Apigenin Story Just Got More Interesting: A Common Flavonoid That Raises Cellular NAD+ A peer-reviewed study shows the plant flavonoid apigenin inhibits CD38, the enzyme that quietly burns through your NAD+ supply. For brands building longevity and metabolic SKUs, this is a mechanism worth understanding. NAD+ has been having […]

Learn More

Exploring Supplement Trends for 2026: What’s Growing, What’s Changing, and What Brands Should Watch

Exploring Supplement Trends for 2026: What’s Growing, What’s Changing, and What Brands Should Watch 2026 is shaping up to be a high-velocity year for supplement innovation—driven by two realities happening at the same time: consumers are demanding more targeted outcomes (focus, sleep, gut, longevity, hydration), while retailers and marketplaces are raising the bar on quality, […]

Learn More